Transcription activity, demonstrated by the level of PD-L1 mRNA expression, was promoted through JAK2/STAT1 pathway, as was shown in pancreatic cancer cells treated with anticancer agents (5-fluorouracil, gemcitabine, or paclitaxel) (Wang et al., 2010). The gene discussed is CD274; the disease is pancreatic neoplasm.